If you are an Ochsner provider and need assistance with this site please email
[email protected]
.
ScholarlyWork@Ochsner
Toggle navigation
Browse
Home
People
Organizations
Research Areas
Publications
Capability Map
Journal of the International AIDS Society
Journal
Overview
Research
Identity
View All
Overview
Publication venue for
STRIIVING: switching to abacavir/dolutegravir/lamivudine fixed dose combination (ABC/DTG/3TC FDC) from a PI, INI or NNRTI based regimen maintains HIV suppression at week 48
. 19.
2016
Research
Category
IMMUNOLOGY
Category
INFECTIOUS DISEASES
Category
Identity
International Standard Serial Number (ISSN)
1758-2652